We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. Show more
Preliminary OvaWatch® volume during Q2 2024 grew 24% over the prior quarter to 1,307 units Preliminary OvaSuiteSM volume during Q2 2024 grew 11% over the prior quarter to 6,471 units AUSTIN...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.16 | -9.41176470588 | 1.7 | 1.7299 | 1.29 | 96538 | 1.48336303 | CS |
4 | -0.11 | -6.66666666667 | 1.65 | 1.7299 | 0.86 | 217674 | 1.2025537 | CS |
12 | -1.78 | -53.6144578313 | 3.32 | 3.38 | 0.86 | 116677 | 1.5559516 | CS |
26 | -2.89 | -65.237020316 | 4.43 | 5.65 | 0.86 | 67534 | 2.08944681 | CS |
52 | -1.11 | -41.8867924528 | 2.65 | 6.75 | 0.86 | 62919 | 3.10358139 | CS |
156 | -71.21 | -97.883161512 | 72.75 | 74.25 | 0.86 | 405177 | 20.40498258 | CS |
260 | -60.56 | -97.5201288245 | 62.1 | 158.1 | 0.86 | 483269 | 43.43315701 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions